Calcineurin Inhibitors Replacement By Ruxolitinib As Graft Versus Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation

被引：1
|
作者：
Zhao, Yanmin [1 ]
Huang, He [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Peoples R China
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-125803
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5674
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation
    Zhao, Yanmin
    Shi, Jimin
    Luo, Yi
    Gao, Fei
    Tan, Yamin
    Lai, Xiaoyu
    Yu, Jian
    Wei, Guoqing
    Huang, He
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (05) : E128 - E133
  • [2] Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients
    Zhang, Xiaoyu
    Zhao, Xiaoli
    Chen, Shulian
    Hao, Mengze
    Zhang, Lining
    Gong, Ming
    Shi, Yuanyuan
    Wei, Jialin
    Zhang, Ping
    Feng, Sizhou
    He, Yi
    Jiang, Erlie
    Han, Mingzhe
    BONE MARROW TRANSPLANTATION, 2024, 59 (07) : 997 - 1005
  • [3] Safety and Efficacy of the mTOR Inhibitor Everolimus as Early Interventional Replacement for Calcineurin Inhibitors In Graft-Versus-Host Disease (GvHD) Prophylaxis After Allogeneic Stem Cell Transplantation
    Sayer, Herbert G.
    Klink, Anne
    Schenk, Thomas
    Treschl, Anne
    Schilling, Kristina
    Hochhaus, Andreas
    BLOOD, 2010, 116 (21) : 960 - 961
  • [4] Calcineurin inhibitor as graft versus host disease prophylaxis in patients with relapsed multiple myeloma undergoing allogeneic stem cell transplantation
    Posada Alcon, L.
    Calbacho Robles, M.
    Hernandez Perez, P.
    Ruiz Gomez, F. A.
    Chinea Rodriguez, A.
    Balerdi Malcorra, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S462 - S463
  • [5] NEUROLOGIC COMPLICATIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH CALCINEURIN-FREE GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS
    Balaguer Rosello, Aitana
    Garcia Gil-Perotin, Sara
    Montoro, Juan
    Villalba, Marta
    Facal, Ana
    Guerreiro, Manuel
    Chorao, Pedro
    Louro, Alberto
    Granados, Pablo
    De La Rubia, Javier
    Sanz, Jaime
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 542 - 543
  • [6] Addition of ruxolitinib in Graft-versus-Host disease prophylaxis for pediatric β-Thalassemia major patients after allogeneic stem cell transplantation: A retrospective cohort study
    Hong, Xiuli
    Chen, Yamei
    Lu, Jingyuan
    Lu, Quanyi
    PEDIATRIC TRANSPLANTATION, 2023, 27 (02)
  • [7] Ruxolitinib plus etanercept for patients with steroid-refractory acute graft versus host disease after allogeneic stem cell transplantation
    Zhao, Yanmin
    Shi, Jinmin
    Luo, Yi
    Tan, Yamin
    Lan, Jianping
    Chen, Lieguang
    Huang, He
    BONE MARROW TRANSPLANTATION, 2019, 54 : 298 - 298
  • [8] Sirolimus combined with tacrolimus as graft-versus-host disease prophylaxis after allogeneic stem cell transplantation
    Mattsson, J.
    Svenberg, P.
    Gustafsson, B.
    Remberger, M.
    Ringden, O.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S234 - S234
  • [9] Reduced Incidence of Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Calcineurin-Free Graft-versus-Host Disease Prophylaxis
    Balaguer-Rosello, Aitana
    Gil-Perotin, Sara
    Montoro, Juan
    Bataller, Luis
    Lamas, Brais
    Villalba, Marta
    Facal, Ana
    Guerreiro, Manuel
    Chorao, Pedro
    Gomez, Ines
    Solves, Pilar
    Louro, Alberto
    Rubia, Javier de la
    Sanz, Miguel Angel
    Sanz, Jaime
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (10): : 610.e1 - 610.e12
  • [10] Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
    Zeiser, R.
    Burchert, A.
    Lengerke, C.
    Verbeek, M.
    Maas-Bauer, K.
    Metzelder, S. K.
    Spoerl, S.
    Ditschkowski, M.
    Ecsedi, M.
    Sockel, K.
    Ayuk, F.
    Ajib, S.
    de Fontbrune, F. S.
    Na, I-K
    Penter, L.
    Holtick, U.
    Wolf, D.
    Schuler, E.
    Meyer, E.
    Apostolova, P.
    Bertz, H.
    Marks, R.
    Luebbert, M.
    Waesch, R.
    Scheid, C.
    Stoelzel, F.
    Ordemann, R.
    Bug, G.
    Kobbe, G.
    Negrin, R.
    Brune, M.
    Spyridonidis, A.
    Schmitt-Graeff, A.
    van der Velden, W.
    Huls, G.
    Mielke, S.
    Grigoleit, G. U.
    Kuball, J.
    Flynn, R.
    Ihorst, G.
    Du, J.
    Blazar, B. R.
    Arnold, R.
    Kroeger, N.
    Passweg, J.
    Halter, J.
    Socie, G.
    Beelen, D.
    Peschel, C.
    Neubauer, A.
    LEUKEMIA, 2015, 29 (10) : 2062 - 2068
12345